Literature DB >> 30851752

Craniofacial Microsomia.

Craig Birgfeld1, Carrie Heike2.   

Abstract

Clinicians use different diagnostic terms for patients with underdevelopment of facial features arising from the embryonic first and second pharyngeal arches, including first and second branchial arch syndrome, otomandibular dysostosis, oculoauriculovertebral syndrome, and hemifacial microsomia. Craniofacial microsomia has become the preferred term. Although no diagnostic criteria for craniofacial microsomia exist, most patients have a degree of underdevelopment of the mandible, maxilla, ear, orbit, facial soft tissue, and/or facial nerve. These anomalies can affect feeding, compromise the airway, alter facial movement, disrupt hearing, and alter facial appearance.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Craniofacial microsomia; Distraction osteogenesis; Goldenhar syndrome; Hemifacial microsomia; Oculoauriculovertebral syndrome; Orthognathic surgery; Phenotypic assessment tool – craniofacial microsomia (PAT-CFM); Virtual surgical planning

Mesh:

Year:  2019        PMID: 30851752     DOI: 10.1016/j.cps.2018.12.001

Source DB:  PubMed          Journal:  Clin Plast Surg        ISSN: 0094-1298            Impact factor:   2.017


  3 in total

1.  Polymethyl Methacrylate (PMMA) in the Treatment of a Case of Hemifacial Microsomia.

Authors:  Anália Cirqueira Milhomem; Isabella Mendes de Souza Jorge; Eduardo Luiz da Costa; Marina Clare Vinaud; Ruy de Souza Lino Júnior
Journal:  Aesthet Surg J Open Forum       Date:  2020-01-23

2.  Surgical Microtia Reconstruction in Hemifacial Microsomia Patients: Current State and Future Directions.

Authors:  Gabriel Bouhadana; Jordan Gornitsky; Eli Saleh; Daniel E Borsuk; Sabrina Cugno
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-08-24

3.  Whole-Exome Sequencing Reveals Rare Germline Mutations in Patients With Hemifacial Microsomia.

Authors:  Xiaojun Chen; Fatao Liu; Zin Mar Aung; Yan Zhang; Gang Chai
Journal:  Front Genet       Date:  2021-05-17       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.